CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2021

Aug 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2021-08-13

Reporting Person: Tierney David S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-13	Common stock, par value $0.001 per share	M	50000	$3.12	Acquired	356874	Direct
2021-08-13	Common stock, par value $0.001 per share	S	50000	$6.0779	Disposed	306874	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-13	Options to purchase common stock	$3.12	M	50000	Disposed	2021-08-28	Common Stock (50000)	Direct

Footnotes

F1: Dr. Tierney has advised the Company that the sale of shares was to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.

F2: The option was granted on August 28, 2014 and previously vested in two equal annual installments.